Mark Cornfeld is an Oncology physician affiliated with Incyte. OpenAlex indexes 47 publications with 1,223 citations (h-index 14); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
227 S 6th St Apt Pc
Philadelphia, PA 191063724
Telephone
609-240-7312Provider last certified this registry record 27 Dec 2022.
Clinical trials
- A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)
Sponsor: Incyte Corporation
- Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401
Sponsor: Idera Pharmaceuticals, Inc.
- Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation
Sponsor: Idera Pharmaceuticals, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Evan Braunstein, MD, PhD
Incyte
Thomas Karasic, MD
Incyte
Sadhna Shankar, MD, MPH
Incyte
Gerard Kennealey, MD
Incyte
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”